Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8871241 | ALIMERA SCIENCES INC | Injectable sustained release delivery devices |
Aug, 2027
(4 years from now) |
Market Authorisation Date: 26 September, 2014
Treatment: NA
Dosage: IMPLANT;INTRAVITREAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8871241 | EYEPOINT PHARMS | Injectable sustained release delivery devices |
Aug, 2027
(4 years from now) | |
US7998108 | EYEPOINT PHARMS | Injector apparatus and method of use |
Jan, 2028
(4 years from now) |
Market Authorisation Date: 12 October, 2018
Treatment: A method of injecting an implant
Dosage: IMPLANT;INTRAVITREAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic